APA   Click to copy
Jarr, K., Ye, J., Kojima, Y., Ye, Z., Gao, H., Schmid, S., … Leeper, N. (2022). The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis. Nature Cardiovascular Research.

Chicago/Turabian   Click to copy
Jarr, K., Jianqin Ye, Y. Kojima, Zhongde Ye, Hua Gao, Sofie Schmid, Lingfeng Luo, et al. “The Pleiotropic Benefits of Statins Include the Ability to Reduce CD47 and Amplify the Effect of pro-Efferocytic Therapies in Atherosclerosis.” Nature Cardiovascular Research (2022).

MLA   Click to copy
Jarr, K., et al. “The Pleiotropic Benefits of Statins Include the Ability to Reduce CD47 and Amplify the Effect of pro-Efferocytic Therapies in Atherosclerosis.” Nature Cardiovascular Research, 2022.

@article{k2022a,
  title = {The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis},
  year = {2022},
  journal = {Nature Cardiovascular Research},
  author = {Jarr, K. and Ye, Jianqin and Kojima, Y. and Ye, Zhongde and Gao, Hua and Schmid, Sofie and Luo, Lingfeng and Baylis, Richard A. and Lotfi, Mozhgan and Lopez, Nicolas and Eberhard, Anne V. and Smith, Bryan R. and Weissman, I. and Maegdefessel, L. and Leeper, N.}
}